Peter Mitterhofer

Peter joined Novavax in 2022 as Cluster Head of DACH, responsible for Germany, Austria and Switzerland.

Previously Peter was CEO of Obvia Pharmaceuticals, where he build up the company from ground.

Peter is a driven Pharma Executive with strong global awareness and leadership with more than 25 year-track record of successful business leadership in top tier US and European leading pharmaceutical, biotech and start-up companies, such as Biogen, Abbvie and UCB. Well-rounded experiences in growing multi-cultural, cross-functional and local teams, driving high performance innovation, cultural change, turnaround execution and building up business and structure from ground.